InvestorsHub Logo
Followers 834
Posts 120252
Boards Moderated 18
Alias Born 09/05/2002

Re: ASPRV post# 2718

Thursday, 09/28/2023 7:58:39 PM

Thursday, September 28, 2023 7:58:39 PM

Post# of 3059
I don’t consider VERU's drug a competitor; VERU's phase-3 trial is restricted to hospitalized patients with ARDS, which is not the market ENTA is seeking to address:

https://finance.yahoo.com/news/veru-reaches-agreement-fda-phase-123000795.html

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News